118430-74-3 Usage
Uses
Used in Organic Synthesis:
3-CYCLOPROPYL-1-METHYL-1H-PYRAZOL-5-AMINE is used as a key intermediate in the synthesis of a variety of organic compounds, contributing to the development of new chemical entities with potential applications in various fields.
Used in Pharmaceutical Industry:
Although its specific uses and effects are not widely documented, 3-CYCLOPROPYL-1-METHYL-1H-PYRAZOL-5-AMINE is known to possess pharmacological activity. It is used as a potential active pharmaceutical ingredient for the development of new drugs, targeting various therapeutic areas.
It is important to handle and use 3-CYCLOPROPYL-1-METHYL-1H-PYRAZOL-5-AMINE in accordance with relevant safety guidelines and regulations to ensure its safe application in research and development processes.
Check Digit Verification of cas no
The CAS Registry Mumber 118430-74-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,8,4,3 and 0 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 118430-74:
(8*1)+(7*1)+(6*8)+(5*4)+(4*3)+(3*0)+(2*7)+(1*4)=113
113 % 10 = 3
So 118430-74-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H11N3/c1-10-7(8)4-6(9-10)5-2-3-5/h4-5H,2-3,8H2,1H3
118430-74-3Relevant academic research and scientific papers
PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRAZOLES
-
Page/Page column 5, (2009/09/08)
The invention relates to an alternative process for the preparation of substituted 5-amino-pyrazoles, in which a carbonyl compound is reacted with a hydrazine derivative and cyanogen chloride to give an N-cyanohydrazone which is cyclized in the presence of a strong base.
QUINAZOLINE DERIVATIVES
-
Page/Page column 121, (2008/06/13)
The invention concerns quinazoline derivatives of Formula (I) or a pharmaceutically-acceptable salt, solvate or pro-drug thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders or in the treatment of disease states associated with angiogenesis and/or vascular permeability.